Literature DB >> 16489474

Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Wuttipong Tirakotai1, Sandra Fremann, Niels Soerensen, Wolfgang Roggendorf, Adrian M Siegel, Hans Dieter Mennel, Yuan Zhu, Helmut Bertalanffy, Ulrich Sure.   

Abstract

OBJECTIVE: According to the hypothesis that paediatric cerebral cavernomas may have different biological activity compared to adult cavernomas, immunohistochemical analysis was used to elucidate the biological nature of paediatric cavernomas. PATIENTS AND METHODS: We examined the histological features and the proliferative and angiogenic capacity of the tissue specimens acquired from 28 paediatric patients. Normal paediatric brain tissues obtained from paediatric autopsy cases were used as a control group. The proliferative activity of the endothelium and the neoangiogenetic capacity were investigated by immunohistochemistry for proliferating cell nuclear antigen (PCNA), Ki-67 epitope (MIB-1), Flk-1 receptor, vascular endothelial growth factor (VEGF), hypoxia-inducible factor (HIF)-1 alpha, and endoglin antibody, respectively. Afterwards, the results of the paediatric lesions were analysed and compared with the correspondent values of previously reported immunohistochemical analysis in adult cavernomas.
RESULTS: Positive immunostaining of VEGF was detected significantly less in paediatric cavernomas compared to adult cases (p<0.05). In contrast, endoglin, a protein that is upregulated during an increased vascular shear stress, was expressed more often in paediatric cavernomas (p<0.05). Neither the expression of the PCNA nor the expression of the HIF-1alpha was found significantly different between paediatric and adult cavernomas. However, the positive immunoreaction for MIB-1 occurred more often in the paediatric cases (p<0.05).
CONCLUSIONS: The immunohistochemical study indicates that paediatric cavernomas are dynamic lesions. The VEGF/Flk-1 associated neoangiogenesis may play a minor role for the biology of paediatric cavernomas, while endoglin seems to act more prominently than previously thought, particularly for the biology of paediatric cavernomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489474     DOI: 10.1007/s00381-006-0044-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  39 in total

Review 1.  De novo cavernoma case report and review of literature.

Authors:  B Massa-Micon; V Luparello; M Bergui; C A Pagni
Journal:  Surg Neurol       Date:  2000-05

2.  Rapid growth in a cavernoma.

Authors:  R J Stacey; K Ashkan; J M Edwards
Journal:  Br J Neurosurg       Date:  2000-12       Impact factor: 1.596

Review 3.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].

Authors:  P Otten; G P Pizzolato; B Rilliet; J Berney
Journal:  Neurochirurgie       Date:  1989       Impact factor: 1.553

4.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

Review 5.  The surgery of cavernomas both supra-tentorial and infra-tentorial.

Authors:  J P Houtteville
Journal:  Adv Tech Stand Neurosurg       Date:  1995

6.  The pathology of vascular ("arteriovenous") malformations.

Authors:  W F McCormick
Journal:  J Neurosurg       Date:  1966-04       Impact factor: 5.115

7.  Biological activity of adult cavernous malformations: a study of 56 patients.

Authors:  Ulrich Sure; Sandra Freman; Oliver Bozinov; Ludwig Benes; Adrian M Siegel; Helmut Bertalanffy
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

8.  Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.

Authors:  L J Kirkegaard; P B DeRose; B Yao; C Cohen
Journal:  Am J Clin Pathol       Date:  1998-01       Impact factor: 2.493

9.  Mixed vascular malformations of the brain: clinical and pathogenetic considerations.

Authors:  I A Awad; J R Robinson; S Mohanty; M L Estes
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

10.  Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor.

Authors:  Keun-Hwa Jung; Kon Chu; Sang-Wuk Jeong; Hee-Kwon Park; Hee-Joon Bae; Byung-Woo Yoon
Journal:  Arch Neurol       Date:  2003-11
View more
  3 in total

1.  Neonatal cavernous angioma located in the basal ganglia with profuse intraoperative bleeding.

Authors:  T Kon; H Mori; K Hasegawa; K Nishiyama; R Tanaka; H Takahashi
Journal:  Childs Nerv Syst       Date:  2006-11-11       Impact factor: 1.475

Review 2.  Spontaneous bleeding into a suprasellar cavernous angioma of a neonate: case report and literature review.

Authors:  Suhas Udayakumaran; Dimitrios Paraskevopoulos; Emanuela Cagnano; Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2010-04-24       Impact factor: 1.475

3.  A systematic review and meta-analysis of surgeries performed for cerebral cavernous malformation-related epilepsy in pediatric patients.

Authors:  Xiangyu Gao; Kangyi Yue; Jidong Sun; Zheng Fang; Yuan Cao; Boyan Zhao; Haofuzi Zhang; Shuhui Dai; Lei Zhang; Peng Luo; Xiaofan Jiang
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.